Why GSK UK Suspended Interest In Nigeria - GSK Chairman

How companies determine who to fire in an economic crunch

November 29, 2022

Why A Drop In Inflation Does Not Necessarily Mean A Drop In Prices Of Commodities

July 17, 2019

The chairman of GlaxoSmithKline Nigeria Plc, Olusegun Osunkeye,
yesterday attributed the rise in the shares of the company in the nation’s capital market as well as the decision to divest its investment from Lucozade and Ribena globally as the major reasons GlaxoSmithKline UK withdrew its earlier plans to stake over N3billion on acquisition of additional 25 per cent in its Nigeria subsidiary, GlaxoSmithKline Consumer Nigeria Plc.